References from Generative AI for Drug Discovery: GPT-2 and LSTM-Based Models for Designing EGFR Inhibitors. Local targets link to admitted publications; unresolved targets remain external evidence.
No reference evidence is available for this admitted work.
References for Generative AI for Drug Discovery: GPT-2 and LSTM-Based Models for Designing EGFR Inhibitors | ResearchHub - ResearchHub
